Thoracic Oncology Group of Australasia

Clinical Trials

Get the latest news, treatments, ASM highlights and topics in lung cancer and mesothelioma from The Thoracic Oncology Group of Australasia (TOGA).

Post Category Filter Radio Buttons
SHERLOCK is a clinical research study, being led by TOGA and coordinated by the NHMRC CTC, looking at the effectiveness of a new treatment combination
TOGA is excited to be part of the European Thoracic Oncology Platform (ETOP) ADOPT-Lung clinical trial, with recruitment expected to open towards the end of
The Inspirational Research Grant has been created from philanthropic donations to increase research into prevention, treatment, or improved lives of those living with thoracic cancers.
OCEANiC is a phase II multi-centre clinical trial targeting patients with resected stage II to IIIA EGFR mutant NSCLC. The trial provides access to Osimertinib
Facing a diagnosis can be a daunting journey, rife with uncertainty and difficult decisions. Among these decisions is the choice of whether to participate in
Three compelling reasons why becoming a participant in cancer clinical trials is not only a noble endeavor but also a decision that can hold profound
Recommendation by the Medical Services Advisory Committee (MSAC).